NANOG and prostate cancer: Another small molecule inhibitor of PIN1, PiB, inhibited both SPOP-mediated NANOG degradation and stemness-associated spheroid formation in prostate cancer cells [197]; the application of PIN1 inhibitors against prostate cancer with wild-type SPOP was suggested by the researchers.